Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

A549 atcc ccl 185

Sourced in United States
About the product

A549 (ATCC CCL-185) is a human alveolar basal epithelial cell line derived from a 58-year-old Caucasian male with lung adenocarcinoma. The cells are adherent, epithelial-like in morphology, and can be used for in vitro studies.

Automatically generated - may contain errors

Market Availability & Pricing

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

64 protocols using «a549 atcc ccl 185»

1

Sulforhodamine B Cytotoxicity Assay for Cancer Cell Lines

2024
The aim of this assay is to evaluate the in vitro cytostatic (ability to delay or arrest tumor cell growth) or cytotoxic (ability to kill tumor cells) activity of the samples being tested. A colorimetric assay, using a sulforhodamine B (SRB) reaction, has been adapted to provide a quantitative measurement of cell growth and viability [12 (link),13 (link)]. This form of assay employs 96-well cell culture microplates. All the cell lines used in this study were obtained from the American Type Culture Collection (ATCC), unless otherwise indicated, and derived from different types of human cancer: A-549 (ATCC CCL-185), lung carcinoma; HT-29 (ATCC HTB-38), colorectal carcinoma; MDA-MB-231 (ATCC HTB-26), breast adenocarcinoma; and PSN-1, pancreatic adenocarcinoma [14 (link)]. Cell lines were maintained in Dulbecco’s Modified Eagle Medium (DMEM) (for A-549, HT-29 and MDA-MB-231) or RPMI (for PSN-1) supplemented with 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin and 100 U/mL streptomycin, at 37 °C, 5% CO2 and 98% humidity. For the experiments, cells were harvested from subconfluent cultures using trypsinization and resuspended in fresh medium before counting and plating.
Cells were seeded in 96-well microtiter plates at 5 × 103 cells per well in aliquots of 150 μL and allowed to attach to the plate surface for 18 h (overnight) in drug-free medium. After that, one control (untreated) plate of each cell line was fixed (as described below) and used for time zero reference value. Culture plates were then treated with test compounds (50 μL aliquots of 4× concentrated compound stock solutions made in complete culture medium) using ten serial dilutions (concentrations ranging from 10 to 0.000262 μg/mL) and triplicate cultures (final concentration of DMSO being 1%). After 72 h treatment, the antitumor effect was measured using the SRB methodology: briefly, cells were washed twice with PBS, fixed for 15 min in 1% glutaraldehyde solution at room temperature, rinsed twice in PBS and stained in 0.4% SRB solution for 30 min at room temperature. Cells were then rinsed several times with 1% acetic acid solution and air-dried at room temperature. SRB was then extracted in 10 mM trizma base solution and the absorbance measured in an automated spectrophotometric plate reader at 490 nm. Effects on cell growth and survival were estimated by applying the NCI algorithm [15 (link)]. Doxorubicin and DMSO (solvent) were used as the positive and negative controls, respectively, in this assay. Prism 9.1.0. from GraphPad was used for the statistical analysis of the cell growth inhibition results. Using the mean ± SD of triplicates, a dose–response curve was automatically generated using nonlinear regression analysis to a 4-parameter logistic curve. Three reference parameters were calculated (NCI algorithm) by automatic interpolation: GI50 = compound concentration that produces 50% cell growth inhibition, as compared to control cultures; TGI = total cell growth inhibition (cytostatic effect), as compared to control cultures and LC50 = compound concentration that produces 50% net cell killing (cytotoxic effect).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

NSCLC Cell Line Seeding and Treatment

2024
The human NSCLC cell lines, A549 (ATCC CCL-185) and H1299 (ATCC CRL-5803), were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were seeded as we reported earlier [34 (link),53 (link),56 (link),68 (link),69 (link),96 (link),97 (link),98 (link)] in 5 mL DMEM/F12 media (GE Healthcare Life Sciences, Pittsburgh, PA, USA), supplemented with 10% FBS, 50 U/mL penicillin, and 50 U/mL streptomycin in 25 cm2 tissue culture flasks. The cells were allowed to grow overnight in an incubator at 37 °C, 95% humidity, and 5% CO2. The cells were counted using a hemocytometer after trypan blue staining. When inhibitors were used, cells were treated with inhibitors targeted against PKC (chelerythrine, 7.5 μM) or p38 MAPK (SB203580, 20 μM) as indicated.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Virus Infection in Human Cell Lines

2024
Human A549 (ATCC CCL-185) and HFF (ATCC SCRC-1041) cell lines and wild-type HAdV5 and HCMV (AD169) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). A 293β5 stable cell line overexpressing the human β5 integrin subunit was kindly provided by Dr. G. Nemerow [29 (link)]. The cell lines were propagated in Dulbecco's modified Eagle's medium (DMEM; Life Technologies/Thermo Fisher Scientific) supplemented as previously reported [30 (link)]. The HAdV5-GFP used in this study was a replication-defective HAdV containing a green fluorescent protein (eGFP) reporter gene cassette, under the regulation of a CMV promoter in place of the E1/E3 regions [31 (link)]. An HAdV-RFP virus expressing the red fluorescent protein (RFP) gene under the regulation of the HAdV major late promoter was kindly provided by Dr. R. Parks (Ottawa Hospital Research Institute, Canada) [32 (link)].
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Cell Culture Protocols for Cancer and Virus Research

2024
The lung
carcinoma A549 (ATCC CCL-185), H1975 (ATCC CRL-5908), and monkey (Cercopithecus aethiopsis) kidney Vero cell line (ATCC
CCL-81) cell lines were purchased from the American Type Cell Culture
Collection (ATCC, Manassas, VA). Dulbecco’s modified Eagle’s
medium (DMEM), Roswell Park Memorial Institute (RPMI), fetal bovine
serum (FBS), penicillin–streptomycin (Pen–Strep), and
trypsin were purchased from Life Technologies (CA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich
(Darmstadt, Germany). The A549 and Vero cells were grown in complete
DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin
solution. The H1975 cells were maintained in RPMI1640 supplemented
with 10% fetal bovine serum and a 1% penicillin/streptomycin solution.
All cell types were routinely grown at 37 °C in a 5% (v/v) CO2 in a humidified incubator.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

In Vitro Assessment of Dust Toxicity

2023
The A549 epithelial lung cell line A549 (ATCC CCL-185) from the
American Type Culture Collection (ATCC) was used in this study. Both
classical (2D) and three-dimensional (3D) cell cultures were employed
to assess the biological effects of the extracted dust samples. The
2D cell cultures were used for evaluating cell viability and the induction
of reactive oxygen species (ROS) production. 3D cell cultures (as
alginate spheroids) were employed to assess interleukin-8 (IL-8) release
and lipidomics studies. Experimental details of cell culture conditions,
biological assays, and lipidomics procedures are available in the Supporting Information.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.